Docetaxel's commerical name is
Taxotere, manufactured by Aventis Corporation, formerly Rhone-Poulenc Rorer. Docetaxel is an anti-
cancer drug that
stabilizes
microtubules during
anaphase of the mitotic cycle, so that a
cell cannot divide. The drug, made from the leaves of
taxus baccatta, the English
yew tree, is offered to breast and lung cancer patients who have exhausted other options.
For more information check one of my master's projects here: http://www-ec.njit.edu/~fbc7330/docetaxel.html